Thorne HealthTech, Inc.
NASDAQ:THRN
10.19 (USD) • At close October 13, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 72.715 | 65.238 | 62.962 | 58.419 | 56.068 | 54.668 | 49.863 | 48.01 | 42.89 | 44.484 | 36.177 | 38.774 | 30.36 | 33.144 |
| Cost of Revenue
| 32.077 | 30.964 | 34.303 | 30.239 | 24.704 | 24.551 | 24.182 | 22.47 | 19.994 | 21.247 | 18.767 | 19.445 | 17.491 | 17.964 |
| Gross Profit
| 40.637 | 34.274 | 28.659 | 28.18 | 31.364 | 30.118 | 25.681 | 25.54 | 22.896 | 23.237 | 17.41 | 19.329 | 12.869 | 15.179 |
| Gross Profit Ratio
| 0.559 | 0.525 | 0.455 | 0.482 | 0.559 | 0.551 | 0.515 | 0.532 | 0.534 | 0.522 | 0.481 | 0.499 | 0.424 | 0.458 |
| Reseach & Development Expenses
| 1.506 | 1.772 | 1.897 | 1.815 | 1.744 | 1.968 | 1.656 | 2.237 | 1.136 | 0.907 | 1.101 | 0.552 | 1.582 | 0.99 |
| General & Administrative Expenses
| 22.471 | 23.578 | 20.28 | 18.34 | 18.506 | 17.638 | 17.912 | 0 | 12.334 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 10.038 | 8.939 | 3.144 | 4.51 | 17.267 | 5.73 | 5.112 | 0 | 5.046 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 32.509 | 32.516 | 23.424 | 22.85 | 35.773 | 23.368 | 23.024 | 24.223 | 17.38 | 15.476 | 16.545 | 13.478 | 15.544 | 13.981 |
| Other Expenses
| 0.237 | 0.335 | 1.298 | 0 | -0.014 | 0.058 | 0.256 | -0.102 | -0.102 | -0.139 | 0.116 | -0.188 | -0.086 | -0.086 |
| Operating Expenses
| 34.015 | 34.288 | 25.321 | 24.665 | 37.517 | 25.336 | 24.68 | 26.46 | 18.516 | 16.383 | 17.646 | 14.03 | 17.125 | 14.971 |
| Operating Income
| 6.623 | 0.32 | 3.338 | 1.904 | -6.153 | 4.782 | 1.001 | -0.92 | 2.817 | 6.854 | -0.236 | 5.299 | -4.257 | 0.209 |
| Operating Income Ratio
| 0.091 | 0.005 | 0.053 | 0.033 | -0.11 | 0.087 | 0.02 | -0.019 | 0.066 | 0.154 | -0.007 | 0.137 | -0.14 | 0.006 |
| Total Other Income Expenses Net
| 0.218 | -0.733 | 1.732 | 1.683 | 0.55 | -0.008 | 1.226 | 2.11 | -1.514 | -1.767 | -0.659 | -0.608 | -0.326 | -0.564 |
| Income Before Tax
| 6.257 | -0.414 | 5.07 | 3.587 | -5.604 | 4.744 | 2.17 | 1.161 | 2.785 | 4.804 | -1.296 | 4.829 | -4.827 | -0.973 |
| Income Before Tax Ratio
| 0.086 | -0.006 | 0.081 | 0.061 | -0.1 | 0.087 | 0.044 | 0.024 | 0.065 | 0.108 | -0.036 | 0.125 | -0.159 | -0.029 |
| Income Tax Expense
| 2.124 | 0.029 | -7.517 | -0.224 | 0.175 | 0.033 | 0.289 | 0.079 | 0.003 | 0.041 | 0.048 | 0.048 | 0.08 | 0.001 |
| Net Income
| 4.446 | -0.443 | 12.547 | 3.739 | -5.778 | 4.979 | 1.606 | 1.029 | -0.088 | 4.706 | -1.297 | 3.577 | -4.95 | -0.688 |
| Net Income Ratio
| 0.061 | -0.007 | 0.199 | 0.064 | -0.103 | 0.091 | 0.032 | 0.021 | -0.002 | 0.106 | -0.036 | 0.092 | -0.163 | -0.021 |
| EPS
| 0.08 | -0.008 | 0.24 | 0.07 | -0.11 | 0.095 | 0.06 | 0.02 | -0.002 | 0.11 | -0.029 | 0.081 | -0.11 | -0.016 |
| EPS Diluted
| 0.08 | -0.008 | 0.24 | 0.07 | -0.11 | 0.095 | 0.01 | 0.01 | -0.002 | 0.092 | -0.025 | 0.07 | -0.097 | -0.013 |
| EBITDA
| 8.549 | 1.881 | 4.29 | 3.477 | -4.643 | 6.19 | 1.257 | -2.065 | 5.554 | 7.7 | -0.174 | 6.677 | -3.396 | 1.069 |
| EBITDA Ratio
| 0.118 | 0.029 | 0.068 | 0.06 | -0.083 | 0.113 | 0.025 | -0.043 | 0.13 | 0.173 | -0.005 | 0.172 | -0.112 | 0.032 |